Literature DB >> 22247013

The novel function of OCT4B isoform-265 in genotoxic stress.

Yuan Gao1, Jianshu Wei, Jin Han, Xia Wang, Guannan Su, Yannan Zhao, Bing Chen, Zhifeng Xiao, Jiani Cao, Jianwu Dai.   

Abstract

OCT4 is a key transcription factor in maintaining the pluripotency and self-renewal of embryonic stem cells (ESCs). Human OCT4 gene can generate three mRNA isoforms (OCT4A, OCT4B, and OCT4B1) by alternative splicing and four protein isoforms (OCT4A, OCT4B-265, OCT4B-190, and OCT4B-164) by alternative splicing or alternative translation initiation. OCT4A is a transcription factor responsible for the stemness of ESCs, while the function of OCT4B protein isoforms is still not clear. We have previously reported that OCT4B-190 functioned in cell stress response. Here, we present another product of OCT4 gene, OCT4B-265, which is upregulated under genotoxic stress in stem cells, and it may function in stress response through p53 signaling pathway. This work gives an insight into the novel function of OCT4B protein isoforms and helps us to understand the complex expression patterns and biological functions of OCT4 gene.
Copyright © 2012 AlphaMed Press.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22247013     DOI: 10.1002/stem.1034

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  10 in total

1.  Prognostication of OCT4 isoform expression in prostate cancer.

Authors:  Marina França de Resende; Ludmilla Thomé Domingos Chinen; Samantha Vieira; Juliano Jampietro; Francisco Paulo da Fonseca; José Vassallo; Luciene Cristina Campos; Gustavo Cardoso Guimarães; Fernando Augusto Soares; Rafael Malagoli Rocha
Journal:  Tumour Biol       Date:  2013-05-01

2.  OCT4B regulates p53 and p16 pathway genes to prevent apoptosis of breast cancer cells.

Authors:  Lu Meng; Hongyu Hu; Huifang Zhi; Yue Liu; Fangyu Shi; Laiguang Zhang; Yanjun Zhou; Aixing Lin
Journal:  Oncol Lett       Date:  2018-05-02       Impact factor: 2.967

3.  OCT4B mediates hypoxia-induced cancer dissemination.

Authors:  Sheng-Chieh Lin; Chi-Hsiu Chung; Chih-Hung Chung; Ming-Han Kuo; Cheng-Han Hsieh; Yu-Fan Chiu; Yi-Shing Shieh; Yu-Ting Chou; Cheng-Wen Wu
Journal:  Oncogene       Date:  2018-09-12       Impact factor: 9.867

4.  Adaptive and Pathogenic Responses to Stress by Stem Cells during Development.

Authors:  Ladan Mansouri; Yufen Xie; Daniel A Rappolee
Journal:  Cells       Date:  2012-12-10       Impact factor: 6.600

5.  The differential expression of OCT4 isoforms in cervical carcinoma.

Authors:  Shao-Wen Li; Xiao-Ling Wu; Chun-Li Dong; Xiu-Ying Xie; Jin-Fang Wu; Xin Zhang
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

6.  Oct4B, CD90, and CD73 are upregulated in bladder tissue following electro-resection of the bladder.

Authors:  Takumi Takeuchi; Akiko Tonooka; Yumiko Okuno; Mami Hattori-Kato; Koji Mikami
Journal:  J Stem Cells Regen Med       Date:  2016-05-30

7.  Alternative Splicing Generates Different 5' UTRs in OCT4B Variants.

Authors:  Ensieh M Poursani; Majid Mehravar; Alireza Shahryari; Seyed Javad Mowla; Bahram Mohammad Soltani
Journal:  Avicenna J Med Biotechnol       Date:  2017 Oct-Dec

8.  A Novel Variant of OCT4 Entitled OCT4B3 is Expressed in Human Bladder Cancer and Astrocytoma Cell Lines.

Authors:  Ensieh M Poursani; Majid Mehravar; Bahram Mohammad Soltani; Seyed Javad Mowla; James E Trosko
Journal:  Avicenna J Med Biotechnol       Date:  2017 Jul-Sep

9.  Influence of conception and delivery mode on stress response marker Oct4B1 and imprinted gene expression related to embryo development: A cohort study.

Authors:  Maria Argyraki; Socrates Katafigiotis; Theofanis Vavilis; Zoe Papadopoulou; Giorgos Tzimagiorgis; Anna-Bettina Haidich; Katerina Chatzimeletiou; Grigoris Grimbizis; Basil Tarlatzis; Maria Syrrou; Alexandros Lambropoulos
Journal:  Int J Reprod Biomed       Date:  2021-03-21

10.  Oct4 confers stemness and radioresistance to head and neck squamous cell carcinoma by regulating the homologous recombination factors PSMC3IP and RAD54L.

Authors:  Jacqueline Nathansen; Vasyl Lukiyanchuk; Linda Hein; Maya-Isabel Stolte; Kerstin Borgmann; Steffen Löck; Ina Kurth; Michael Baumann; Mechthild Krause; Annett Linge; Anna Dubrovska
Journal:  Oncogene       Date:  2021-06-02       Impact factor: 9.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.